Software

Sarcoidosis Resources

General Information

Sarcoidosis information within this website has in part been adapted from information published by the United States National Heart Lung & Blood Institute.

References

  • American Thoracic Society. Medical Section of the American Lung Association: statement on sarcoidosis. Am J Respir Cri Care Med. 1999;160:736-55.
  • Askling J, Grunewald J, Eklund A, et al. Increased risk for cancer following sarcoidosis. Am J Respir Cri Care Med. 1999;160(5 Pt 1:1668-72).
  • Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis Vasc and Diffuse Lung Dis. 1997;14:121-30.
  • Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc and Diffuse Lung Dis. 2000;17:60-6.
  • Costable U. Sarcoidosis: clinical update. Eur Respir J. 2001;18(suppl32):56s-68s.
  • Hunninghake GW, Costable U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc and Diffuse Lung Dis. 1999;16:149-73.
  • McGrath DS, Goh N, Foley PJ, et al. Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasc and Diffuse Lung Dis. 2001;18:149-64.
  • Newman LS, Rose CS, Maier LA. Sarcoidosis. NEngl J Med.1997;336(17):1224-34.
  • Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA.2002;287(10):1301-7.
  • Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-a therapy. Ann Internal Med. 2001;135(1):27-31